In the tumor tissue, DC were found at 5.8 × 104 cells/gram tumor or 0.75% of total CD45 + cells for the combination treatment which were significantly increased compared to untreated (1.9 × 104 cells/gram tumor or 0.37%, p < 0.01), vehicle (2.3 × 104 cells/gram tumor or 0.34%, p < 0.01), and anti-mCTLA-4 (2.4 × 104 cells/gram tumor or 0.43%, p < 0.05) (Online Resource Figure S6). The gene discussed is PTPRC; the disease is neoplasm.